Trinucleotide Repeat Disorders

Seminars in Pediatric Neurology

Volumn 14, Issue 1, 2007, Pages 26-33

  Lutz, Richard E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYGLUTAMINE;

APOPTOSIS; ARTICLE; AUTONOMIC DYSFUNCTION; BRAIN ATROPHY; DISEASE COURSE; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FRAGILE X SYNDROME; FRIEDREICH ATAXIA; GENETIC TRANSCRIPTION; HUMAN; HUNTINGTON CHOREA; INHERITANCE; KENNEDY DISEASE; MENTAL DEFICIENCY; MITOCHONDRION; MOLECULAR DYNAMICS; MYOTONIC DYSTROPHY; NERVE FIBER TRANSPORT; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PATHOGENESIS; PROTEIN DEFECT; SPINOCEREBELLAR DEGENERATION; TRINUCLEOTIDE REPEAT;

ANIMALS; BRAIN DISEASES; FRAGILE X SYNDROME; HUMANS; SPINOCEREBELLAR DEGENERATIONS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 33847241277     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spen.2006.11.006     Document Type: Article

References (35)

1. Everett C.M., and Wood N.W. Trinucleotide repeats in neurodegenerative disease. Brain 127 (2004) 2385-2405
2. Goldberg P. The ups and downs of parting COMPany poly-aspartic acid tract: A novel expansion-contraction mutation. Clinic Genet 56 4 (1999) 259-261
3. van de Warrenburg B.B., Sinke R.J., and Kremer B.J. Recent advances in hereditary spinocerebellar ataxias. Neuropathol Exp Neurol 64 3 (2005) 171-180
4. Pearson C.E., Nichol Edamura K., and Cleary J.D. Repeat instability: Mechansims of dynamic mutations. Nat Rev Genet 6 10 (2005) 729-742
5. Sinden R.R., Potaman V.N., Oussatcheva E.A., et al. Triplet repeat DNA structures and human genetic disease: Dynamic mutations from dynamic DNA. J Biosci 27 (2002) 53-65
6. Otto C.J., Almqvist E., Hayden M.R., et al. The 'flap' endonuclease gene FEN1 is excluded as a candidate gene implicated in the CAG repeat expansion Huntington disease. Clin Genet 59 (2001) 122-127
7. Pearson C.E., Ewela A., Acharya S., et al. Human MSH2 binds to trinucleotide repeat DNA structures associated with neurodegenerative diseases. Hum Mol Genet 6 (1997) 1117-1123
8. Mirken S.M. DNA structures, repeat expansions and human hereditary disorders. Curr Opin Struct Biol 16 3 (2006) 351-358
9. Morfini G., Pigino G., and Brady S.T. Polyglutamine expansion diseases: Failing to deliver. Trends Mol Med 11 2 (2005) 64-70
10. Wells R.D., Deere R., Hebert M.L., et al. Advances in mechanisms with genetic instability related to hereditary neurological diseases. Nucleic Acids Res 33 12 (2005) 3785-3798
11. Brown L.Y., and Brown S.A. Alanine tracts: The expanding story of human illness in trinucleotide repeats. Trends Genet 20 1 (2004) 51-58
12. Schiwach R.S., and Norbury C.J. A controlled psychiatric study of individuals at risk for Huntington disease. Br J Psychiatry 165 (1994) 500-505
13. Rubinsztein D.C., Leggo J., et al. Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proc Natl Acad Sci U S A 94 (1997) 3872-3876
14. Katsuno M., Adachih A., et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med 9 (2003) 768-773
15. Trochet D., O'Brien L., et al. PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome. Am J Hum Genet 76 (2005) 421-426
16. OMIM 164300, Oculopharyngeal Muscular Dystrophy; OPMD, Available at: www.ncvi.nlm.nih.gov/entrez/dispomim.cgi?id=164300.
17. OMIM 125370, Dentatorubral-Pallidoluysian Atrophy; DRPLA. Available at: http://www.ncvi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=125370.
18. Bidichandani S.I., Shizawa T., and Patel P.I. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am J Hum Genet 62 1 (1998) 111-121
19. Rustin P., von Kleist-Retzow J.C., et al. Effect of idebenone on cardiomyopathy and Friedreich's ataxia: A preliminary study. Lancet 354 (1999) 477-479
20. Linch D.R., Farmer J.M., et al. Friedreich ataxia: Effects of genetic understanding on the clinical evaluation and therapy. Arch Neurol 59 (2002) 743-747
21. Ranum L.P.W., and Day J.W. Myotonic dystrophy: RNA pathogenesis comes into focus. Am J Hum Genet 74 (2004) 793-804
22. Jacquemont S., Hagerman R.J., et al. Fragile X premutation tremor/ataxia syndrome: Molecular, clinical, and neuroimaging correlates. Am J Hum Genet 72 (2003) 869-878
23. Blomquist H.K., Bohman M., et al. Frequency of Fragile X syndrome in infantile autism. A Swedish multicenter study. Clin Genet 27 (1985) 113-117
24. Schaefer G.B., and Lutz R.E. Diagnostic yield in the clinical genetic evaluation of autism spectrum disorders. Genet Med 8 (2006) 549-556
25. Murray A., Ennis S., and Morton N. No evidence for parent of origin influencing premature ovarian failure in Fragile X premutation carriers. Am J Hum Genet 67 1 (2000) 253-254
26. Hagerman R.J., Leehy M., et al. Intention tremor, Parkinsonism, and generalized brain atrophy in male carriers of Fragile X. Neurology 57 1 (2001) 127-130
27. Hagerman R.J., Leavitt B.R., et al. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet 74 5 (2004) 1051-1056
28. Fu Y.-H., Kuhl D.P.A., et al. Variation of the CGG repeat at the Fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell 67 (1991) 1047-1058
29. Edamura K.N., Leornard M.R., et al. Role of replication and CpG methylation in Fragile X syndrome CGG deletions in primate cells. Am J Hum Genet 76 2 (2005) 302-311
30. Chiurazzi P., and Nari G. Pharmacological reactivation of inactive genes: The Fragile X experience. Brain Res Bull 56 (2001) 383-387
31. Bird TD: Hereditary ataxia overview. Available at: www.genetests.org/servlet/access?db=geneclinics&site=gt&id=8888891&key=zDedSYuboePLe&gry=&fn=y&fw=Jxyq&filename=/profiles/ataxias/index.html.
32. Nance M.A. Clinical aspects of CAG repeat disease. Brain Pathol 7 (1997) 881-900
33. Alfen N., Sinke R.J., et al. Intermediate CAG repeat lengths (53,54) for MJD/SCA3 are associated with an abnormal phenotype. Ann Neurol 49 (2001) 805-808
34. Yvert G., Lindenberg K.S., et al. Expanded polyglutamines induced neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice. Hum Molec Genet 9 (2000) 2491-2506
35. Cholfin J.A., Soprido M.J., et al. The SCA12 mutation as a rare cause of spinocerebellar ataxia. Arch Neurol 58 (2001) 1833-1835